Accord Healthcare AG - Temozolomid Accord 180 mg, Kapseln | | 67020 | | 05 | | Temozolomid Accord 180 mg | | Kapseln | | L01AX03 | | Temozolomid | | 02.12.2019 | | |
| Composition | temozolomidum 180 mg, lactosum 131.4 mg, silica colloidalis anhydrica, carboxymethylamylum natricum A corresp. natrium 1.21 mg, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, aqua, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, kalii hydroxidum, E 172 (nigrum), pro capsula. | Packungsbestandteile | | Capsules | | | Principe actif | Concentr. |
---|
Temozolomide | 180 mg |
| BAG: Principe actif | Concentr. |
---|
Temozolomide | 180 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | (Rubrum) | | | Acidum Stearicum | | | Acide Tartarique | | | Aqua | | | Carboxymethylamylum Natricum A | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Lactosum | 131.4 mg | | Pro Capsula | | | Silica Colloidalis Anhydrica | | |
| |
| |
|